News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Mergers and Acquisitions
Intrexon Corporation To Acquire Okanagan Specialty Fruits 3/2/2015
Mesa Labs (MLAB) Acquires Its UK And Germany Distribution Of Biological Indicators 3/2/2015
Boston Scientific (BSX) Snags Endo International (ENDP)'s Urology Portfolio in Deal Worth $1.65 Billion 3/2/2015
Cardinal Health (CAH) Ponies Up $1.944 Billion Cash for Johnson & Johnson (JNJ)'s Cordis (JNJ) 3/2/2015
Teva Pharmaceutical Industries (TEVA) Announces Sale Of Sellersville, PA Facility 3/2/2015
ICON Completes Acquisition Of MediMedia Pharma Solutions 3/2/2015
Genstar Capital L.P. Backed eResearch Technology Inc. (ERT) (ERES) To Acquire PHT Corporation 3/2/2015
Bay Area's Pharmacyclics (PCYC) Mulls Possible $18 Billion Sale; Johnson & Johnson (JNJ),Novartis AG (NVS) Interested 2/27/2015
ERT To Acquire PHT Corporation 2/27/2015
Omnicell Signs Agreement To Acquire Germany-Based Pharmacy Automation Provider, MACH4 Pharma Systems 2/27/2015
Mylan Inc. (MYL) Completes Acquisition Of Abbott (ABT)'s Non-U.S. Developed Markets Specialty And Branded Generics Business 2/27/2015
Allergan (AGN) CEO May Pocket $100 Million If Terminated After Buyout 2/26/2015
Biota Pharmaceuticals, Inc. (BOTA) Grabs Anaconda Pharma in $38 Million Deal 2/26/2015
Cipher Pharmaceuticals (DND.TO) Acquires Three Products From Astion Pharma 2/26/2015
Tekmira (TKMR) Announces Update To Its Proxy Circular On The Proposed Business Combination With Oncore 2/26/2015
JSR Corporation And KBI BioPharma Agree To Acquisition; INCJ And CMIC Of Japan Also Participate 2/26/2015
Shares Rise as Suitors Like Shire (SHPGY) and BioMarin (BMRN) Circle Around PTC Therapeutics (PTCT) 2/25/2015
Phosphagenics Limited (POH.AX) Decides To Sell BioElixia Cosmetics Brand 2/25/2015
Bristol-Myers Squibb (BMY) Snaps Up Private Cancer Drugmaker in $1.25 Billion Buyout 2/24/2015
Shire (SHPGY) Beefs Up Late-Stage Pipeline With $70 Million+ Meritage Pharma Buy 2/24/2015
BioNJ Announces Purchasing Consortium, Designed With Member Savings In Mind 2/24/2015
Ipsen (IPN.PA) Enters Into Option Agreement To Acquire Canbex Therapeutics 2/24/2015
Eli Lilly (LLY) Steers Clear of Deals as It Eyes Moon Shot Drugs 2/24/2015
Spending Spree Continues as Valeant (VRX) Officially Snags Salix (SLXP) for $14.5 Billion 2/23/2015
Bayer AG (BAYZF) May Have a Buyer for Diabetes Biz 2/23/2015
Ferring Pharmaceuticals Acquires Novel Drug Delivery Technology From CTCBIO Inc. 2/23/2015
EXCLUSIVE: Evercore ISI Breaks Down Valeant (VRX) / Salix (SLXP) Deal By the Numbers 2/23/2015
Shire (SHPGY) Completes Acquisition Of NPS Pharmaceuticals, Inc. (NPSP) 2/23/2015
Sosei Snags UK Biotech Firm Heptares for $400 Million 2/23/2015
Marathon Pharmaceuticals, LLC Prepares For Launch Of New Rare Disease Treatments By Selling Non-Strategic Products To Valeant (VRX) Including Isuprel And Nitropress 2/23/2015
Management Buy Out Of Synexus Backed By LDC; The Deal Will Enable It To Further Expand Its Global Network 2/23/2015
Actavis (ACT) to Officially Adopt Allergan (AGN) Name 2/20/2015
Ferring Pharmaceuticals Acquires Two Phase III Ready Orthobiologic Product Candidates From BioSET 2/19/2015
Actavis (ACT) Not Done, Still Eyes "Couple Billion Dollar" Deals to Fill Pipeline 2/19/2015
Endo Pharmaceuticals (ENDP) Rumored to be Battling Shire (SHPGY), Valeant (VRX) for Salix (SLXP)'s Affections 2/18/2015
Manhattan Scientifics, Inc. To Immediately Receive $8 Million As It Reacquires Its Nano-Structured Metals Technology And Related Intellectual Property And Equipment 2/18/2015
Crown Bioscience, Inc. Buys PDX Unit From Molecular Response (MRL) 2/18/2015
Amneal, Pfizer (PFE), Novartis AG (NVS) Eye Takeover of CLARIS Lifesciences's Injectables Biz 2/17/2015
Charles River Laboratories Hunts for M&As; Close to Sealing Deal With Unnamed Drug Discovery Startup 2/17/2015
Vaxin, Inc. Enters Definitive Agreement To Acquire Immune Targeting Systems (ITS) Ltd.; Secures $16M In New Financing 2/17/2015
Novartis AG (NVS) Eyes Israeli Companies 2/16/2015
Allergan (AGN) CEO's Take on How to Survive an Activist Attack 2/16/2015
Look Out Valeant (VRX), Shire (SHPGY) Wants to Continue Spending Spree With Salix (SLXP) Bid 2/16/2015
Week in Review: Cellular Biomedicine Group (CBMG) In-Licenses Cancer Immunotherapy From China 2/16/2015
Valeant (VRX) Secures Financing to Make Rumored $9.6 Billion Bid for Salix (SLXP) 2/13/2015
Gilead (GILD) Hungry For Oncology M&A, Bullish On Hep C Cash Flow: Citi 2/13/2015
Intrexon Corporation Snaps Up Belgium Startup ActoGeniX for $60 Million 2/13/2015
Actavis (ACT) To Divest Pharmatech, Inc. To TPG 2/13/2015
It's Official: Valeant (VRX) to Buy Bankrupt Vaccine Maker for $400 Million Cash 2/12/2015
KYTHERA Biopharmaceuticals, Inc. (KYTH) Acquires Worldwide Rights To Clinical Compound And Key Intellectual Property For Potential Novel Treatment Of Hair Loss 2/11/2015
Zoetis (ZTS) Completes Purchase Of Animal Health Assets Of Abbott Laboratories (ABT) 2/11/2015
AmerisourceBergen Corporation (ABC) Announces Expiration Of The Hart-Scott-Rodino Waiting Period For Amerisourcebergen’s Proposed Acquisition Of MWI Veterinary Supply 2/11/2015
GlaxoSmithKline (GSK) Takes Full Control of GlycoVaxyn AG for $190 Million 2/11/2015
Actavis (ACT) Unloads Another Product Line for $50 Million 2/10/2015
BIOCEO15: Financial Panel Sees Deal-Making Up in 2015, Names CAR-T, Plaque Attackers as Hot Targets 2/9/2015
Pfizer (PFE) Not Done With Deals, May Still Break Up After $17 Billion Buy 2/9/2015
Cellular Biomedicine Group (CBMG) Acquires CAR-T Technology From China Hospital 2/9/2015
Cellular Biomedicine Group (CBMG) Acquiring Chinese PLA General Hospital's CAR-T (CD19/CD20/CD30/EGFR) Immuno-Oncology Technology And Clinical Data 2/9/2015
Valeant (VRX) Ups Bid for Dendreon (DNDN) Assets to $400 Million After Competing Offers Come In 2/6/2015
AstraZeneca PLC (AZN) Who? Pfizer (PFE) Snatches Up Hospira for $17 Billion Cash 2/6/2015
AstraZeneca PLC (AZN) Slams Down $600 Million for Actavis (ACT) Lung Unit 2/5/2015
Roper Industries Announces Two Medical Software Acquisitions 2/5/2015
Oncore And Tekmira (TKMR) Files For Merger – Releases Further Details About License Agreement With NeuroVive Pharmaceutical AB 2/5/2015
Dendreon Corporation (DNDN) Enters Into Amended Agreement With Valeant (VRX) In Connection With Court-Supervised Sales Process 2/5/2015
Deal-Hungry Valeant (VRX) Eyes Salix Pharmaceuticals, Ltd. (SLXP) as Its Latest Takeover Target 2/5/2015
Harbin Gloria Pharmaceuticals (002437.SZ) Acquires Shanxi Powerdone For $380 Million 2/4/2015
The Medicines Company (MDCO) Acquires Annovation Biopharma, Inc. 2/4/2015
Hainan Shuangcheng Buys Hangzhou Ausia Biotech Stake For $154 Million 2/4/2015
Mylan Inc. (MYL) to Become a Women's Healthcare Powerhouse With $800 Million Buy 2/3/2015
VWR Acquires National Biochemicals 2/3/2015
Sanofi (SAN.PA)'s Increased Stake in Alnylam Pharmaceuticals (ALNY) Points Toward a Possible Acquisition 2/2/2015
Dendreon Corporation (DNDN) Gets $296 Million Cash Bid From Deal-Hungry Valeant (VRX) for Provenge Assets as Bankruptcy Auction Looms 2/2/2015
ICON Snaps Up MediMedia Pharma Solutions for $120 MIllion Cash 2/2/2015
Matinas BioPharma Establishes Lipid-Based, Anti-Infective Platform, With Acquisition Of Aquarius Biotechnologies Inc. 1/30/2015
BioMarin (BMRN) Announces Final Results Of Tender Offer For ProSensa Holding N.V. (RNA)'s Shares And Completion Of Subsequent Offering Period 1/30/2015
Endo Pharmaceuticals (ENDP) Completes Acquisition Of Auxilium Pharmaceuticals (AUXL) 1/30/2015
China TCM Ltd. Pays $1.3 Billion For 81% Stake In Tianjiang Pharma 1/30/2015
With Profits Down By 52 Percent, Pfizer (PFE) Investors May Pressure for an M&A, a Breakup, or Both 1/29/2015
Pharma Giant Merck & Co. (MRK) Scoops Up UK Software Firm for Undisclosed Amount 1/29/2015
Mylan Inc. (MYL) Shareholders Overwhelmingly Approve Agreement Implementing Acquisition Of Abbott Laboratories (ABT)'s Non-U.S. Developed Markets Specialty And Branded Generics Business 1/29/2015
AstraZeneca PLC (AZN) Rumored to be Stalking Massachusetts's Ariad Pharmaceuticals, Inc. (ARIA) 1/29/2015
Pfizer (PFE)'s $33 Billion Cash Pile Has Everyone Speculating 1/28/2015
Amerita, A Subsidiary Of PharMerica, Accelerates Growth With The Acquisition Of Infusionrx 1/28/2015
Actavis (ACT)' Buying Spree Continues With $460 Million Deal 1/27/2015
BioDelivery Sciences International (BDSI) Acquires North American Marketing Authorizations For ONSOLIS From MEDA 1/27/2015
genae Buys e-novex 1/27/2015
Biolin Scientific Acquires The Key Patent Protecting Multi-Hole, High-Throughput Ion Channel Screening 1/27/2015
Spectro Scientific Strengthens Its Fluid Analysis Leadership Role With Acquisition Of On-Site Analysis, Inc. 1/27/2015
Pressure Lead Pfizer (PFE) CEO to Approach Teva Pharmaceutical Industries Limited (TEVA) Late Last Year 1/26/2015
Novartis AG (NVS) CEO Taking a Hard Look at Swiss Costs, Possible Bolt-On Acquisitions 1/26/2015
AMATSIGROUP Acquires SEPS Pharma In Belgium, To Continue Its International Expansion And Strengthen Its Formulation Expertise 1/26/2015
Intrexon Corporation Snaps Up Remaining Stake In Exemplar Genetics 1/26/2015
Centene Corporation To Acquire Oregon-Based Agate Resources 1/26/2015
3SBio Inc. (SSRX) Acquires Sirton Pharmaceuticals SpA 1/26/2015
AmerisourceBergen Corporation (ABC) Commences Tender Offer To Acquire MWI Veterinary Supply 1/26/2015
Valeant (VRX) CEO Fesses Up to What Went Wrong in Pursuit of Allergan (AGN) 1/23/2015
Aspen Pharmacare Ltd. Grabs Rights to Novartis AG (NVS)'s Mono-Embolex for $142.3 Million 1/23/2015
Array BioPharma, Inc. (ARRY) Announces Agreement To Acquire ENCORAFENIB (LGX818) 1/23/2015
Hubei Biocause Pharma Buys Guohua Life Insurance Stake For $1.2 Billion 1/23/2015
With Cash in the Bank, Incoming Takeda (TKPYY) CEO Eyes M&A Opportunities 1/22/2015
Alkame Holdings, Inc. Closes Acquisition Of Intellectual Property And Assets Of Xtreme Technologies, Inc. 1/22/2015
CollabRx, Inc. And Medytox Solutions Sign Non-Binding Letter Of Intent For Possible Business Combinatio 1/22/2015
Plagued By Inventory Problems, Salix Pharmaceuticals, Ltd. (SLXP) Finally Brings In Advisors to Explore Sale 1/21/2015
Piramal Snaps Up Coldstream Laboratories Inc. for $30.65 Million 1/21/2015
Endonovo Therapeutics Enters Into A $3 Million Equity Purchase Agreement With Kodiak Capital Group, LLC 1/21/2015
Merck & Co. (MRK) Completes Tender Offer To Acquire Cubist Pharmaceuticals, Inc. (CBST) 1/21/2015
Frontier Scientific Inc. Expands With Ag-Chem Acquisition 1/21/2015
Regado Biosciences, Inc. (RGDO) And Tobira Therapeutics Inc. Merger Agreement Conference Call Set For 8:30 A.M. EST Today, Jan. 20 1/20/2015
NeuroVive Pharmaceutical AB: Merger Between Oncore And Tekmira (TKMR) Includes Development Of NVP018 For The Treatment Of Hepatitis B 1/20/2015
Boehringer Ingelheim Corporation Considering Sale of Its U.S.-Based Generics Biz 1/19/2015
Buying Spree Continues as Roche (RHHBY) Picks Up Trophos in $540 Million Deal 1/19/2015
Depomed, Inc. (DEPO) Smacks Down $1.05 Billion for Johnson & Johnson (JNJ)'s Pain Drug Franchise 1/19/2015
Merger Between Oncore And Tekmira (TKMR) Includes Development Of NVP018 For The Treatment Of Hepatitis B 1/19/2015
BioMarin (BMRN) Announces Completion Of Tender Offer For ProSensa Holding N.V. (RNA)'s Shares And Commences Subsequent Offering Period 1/15/2015
Troubled Regado Biosciences, Inc. (RGDO) Finds a Way Out With $60 Million Merger Deal Tobira Therapeutics Inc. 1/14/2015
With Expectations of Tripling Earnings by 2020, Could Celgene (CELG) Be a Takeover Target in 2015? 1/13/2015
Fresh Off Its Biggest Buy Yet, Shire (SHPGY) Already Hints at Another One 1/13/2015
MannKind Corporation (MNKD) Probably Not Looking for Sanofi (SAN.PA) Merger: Analyst 1/13/2015
AmerisourceBergen Corporation (ABC) To Acquire MWI Veterinary Supply, The Leading Animal Health Distribution Company In The United States 1/12/2015
Biogen Idec (BIIB) Snatches Up UK Pain Drug Developer for $675 Million 1/12/2015
Retrophin (RTRX) Snags Cholic Acid Rights From Asklepion Pharmaceuticals in $78 Million Deal 1/12/2015
Tekmira (TKMR) And Oncore Announce Merger Agreement To Create Leading Global Hepatitis B Virus Company 1/12/2015
Oculus Innovative Sciences, Inc. (OCLS) Enters Into Agreement To Sell Ruthigen Shares For $5.5 Million In Event Of Ruthigen Merger 1/12/2015
Aegerion Pharmaceuticals, Inc. (AEGR) Completes Acquisition Of MYALEPT® 1/12/2015
Teva Pharmaceutical Industries Limited (TEVA) May Need to Jump Onto the Takeover Bandwagon Soon 1/12/2015
Amarantus BioSciences, Inc. Announces Acquisition Of Specialized Neuro-Diagnostics Company, DioGenix 1/12/2015
Actavis (ACT) And Allergan (AGN) Announce Early Termination Of Hart-Scott-Rodino Waiting Period For Actavis' Pending Acquisition Of Allergan And Record Dates For Shareholder Meetings 1/12/2015
Shire (SHPGY) Officially Snaps Up NPS Pharmaceuticals, Inc. (NPSP) in $5.2 Billion Deal 1/12/2015
Roche (RHHBY) Pays $1.03 Billion for Majority Stake in Foundation Medicine, Inc. (FMI) 1/12/2015
WuXi PharmaTech Co., Ltd. Acquires NextCode Health For $65 Million 1/9/2015
BioSpace (DHX) Poll Finds Massive Support for Pfizer (PFE), AbbVie (ABBV) Bid 1/9/2015
Could Pfizer (PFE) Be Eyeing AbbVie (ABBV)? 1/9/2015
Cipher Pharmaceuticals (DND.TO) Acquires Assets Of Melanovus Oncology Inc. 1/9/2015
WuXi PharmaTech Co., Ltd. Acquires NextCode Health To Create Global Leader In Genomic Medicine 1/9/2015
Buying Spree Still On; Pfizer (PFE), Shire (SHPGY) Lead the Hunt 1/8/2015
Egalet Acquires/Licenses Two Innovative Approved Pain Products 1/8/2015
Harvard Bioscience Inc. (HBIO) Acquires All Operations Of HEKA Electronik 1/8/2015
BTG plc (BTG.L): Completion Of The Acquisition Of PneumRx Inc. 1/8/2015
Horizon Discovery Group plc Acquires Haplogen Genomics GmbH 1/8/2015
Advanced Accelerator Applications Fully Acquires Atreus Pharmaceuticals, Inc.; Enrolls First Patient In A Phase 1/2 Clinical Trial For Its Key Diagnostic Candidate Annexin V-128 In Rheumatoid Arthritis And Ankylosing Spondylitis 1/8/2015
Crown Bioscience, Inc. Expands Operations And Re-Brands UK Site 1/8/2015
Adaptive Biotechnologies Banks $94 Million, Buys Bay Area's Sequenta, Inc. 1/8/2015
Cipher Pharmaceuticals (DND.TO) Acquires Canadian Commercialization Rights To Novel Antibacterial Compound Ozenoxacin 1/7/2015
NanoViricides, Inc. (NNVC.PK) Completes Purchase Of cGMP-compliant Pilot Production Facility 1/7/2015
China Medical System Acquires Rights To Novartis AG (NVS) Drugs 1/7/2015
Gilead Sciences, Inc. (GILD) Snaps Up Liver Disease Treatment from Phenex Pharmaceuticals AG in $470 Million Deal 1/6/2015
Dohmen Life Science Services Acquires Chicago Company Focused on Rare Disease Marketing 1/6/2015
Diagnovus Acquired By Aegis Sciences Corporation 1/6/2015
Cardio3 BioSciences Moves Into Oncology With $182 Million Deal 1/6/2015
Mapi Completes The Acquisition Of Select Life Sciences Services 1/6/2015
StoneCalibre Portfolio Company Anatrace Acquires Life Science Tools and Reagents Provider Microlytic 1/6/2015
Synchrogenix, Certara Corporation’s Regulatory And Medical Writing Consultancy, Acquires ClinGenuity 1/6/2015
Pfizer (PFE) Takes Controlling Interest In Startup; Grabs Access of Preclinical CMV Candidate 1/5/2015
Arrowhead Research Corporation (ARWR) Soars on Rumor of Gilead Sciences, Inc. (GILD)'s Interest 1/5/2015
Sihuan Pharmaceutical And Partners Pay $67 Million For Nanjing Hospital 1/5/2015
Chevron Phillips Chemical Completes Sale Of Its Ryton® PPS Business To Solvay 1/5/2015
Eli Lilly (LLY) Finalizes Novartis AG (NVS) Animal Health Acquisition 1/2/2015
Valeant (VRX) Possibly Eyeing Dental Device Makers Such as Align Technology, Inc. (ALGN) and DENTSPLY International Inc. (XRAY) in 2015: Analysts 1/2/2015
SRF Snaps Up DuPont (DD)'s Pharma Propellant Biz for $20 Million 1/2/2015
22nd Century Group, Inc. Acquires Important Intellectual Property From The National Research Council Of Canada And Announces Hiring Of 10 New Employees At Factory 12/29/2014
AstraZeneca PLC (AZN) CEO Believes New Pfizer (PFE) Bid Unlikely 12/29/2014
BioMarin Pharmaceutical Inc. (BMRN) And ProSensa Holding N.V. (RNA) Announce Expiration Of The Hart-Scott-Rodino Waiting Period For Biomarin's Proposed Acquisition Of Prosensa 12/29/2014
Spending Spree Continues as Actavis (ACT) Considers Near $3 Billion Bid for Almirall 12/24/2014
Eli Lilly (LLY) Must Sell Dog Heartworm Line to Buy Novartis AG (NVS)'s Animal Health Unit 12/23/2014
Oragenics, Inc. (OGEN) Exploring Strategic Alternatives for OTC Probiotics Biz 12/23/2014
Roivant Acquires SB742457 From GlaxoSmithKline (GSK) 12/23/2014
Abbott Laboratories (ABT) Completes Acquisition Of Topera 12/23/2014
Phagelux Announces Acquisition Of Novel Delivery Systems 12/23/2014
Acquisition Of Sigma-Aldrich Corporation (SIAL) By Merck KGaA (MKGAF.PK), Darmstadt, Germany, Receives U.S. Antitrust Clearance 12/23/2014
Roche (RHHBY) To Pay Up To $489 Million For Next-Gen Antibody Firm Dutalys 12/22/2014
Sartorius To Sell Its Industrial Technologies Division To Minebea Co., Ltd. 12/22/2014
Merck & Co. (MRK) Begins Tender Offer To Acquire Cubist Pharmaceuticals, Inc. (CBST) 12/19/2014
Institute of Biotechnology, Prague And TATAA Biocenter Expands Offerings On Single Cell Profiling With ALS CellCelector™ 12/19/2014
Dr. Reddy's Laboratories Ltd. (RDY) Closes The Acquisition Of Habitrol® Brand From Novartis AG (NVS) 12/19/2014
Merck & Co. (MRK) Snaps Up Swiss Biotech In $375 Buyout Deal 12/19/2014
Hedge Fund Takes Stake In Salix Pharmaceuticals, Ltd. (SLXP); Other Top Investors Push For Sale Of Company 12/19/2014
Shire (SHPGY) May Spend AbbVie (ABBV) Breakup Fee On NPS Pharmaceuticals, Inc. (NPSP); NPS Surges On Rumor 12/19/2014
Roche (RHHBY) Acquires Bina Technologies And Enters The Genomic Informatics Market 12/19/2014
KCR Acquires Project Portfolio From Ukrainian CRO AXIS 12/18/2014
FUJIFILM Completes Acquisition Of Kalon Biotherapeutics 12/18/2014
Prima Biomed (PRR.AX) Completes Immutep S.A. Acquisition 12/18/2014
RedHill Biopharma Ltd. (RDHL) Acquires Technology From University of Minnesota As Part Of Ongoing RHB-104 Phase 3 Crohn's Program 12/18/2014
UCB SA Terminates $1.53 Billion Sale Of Generic Drug Unit To Buyout Firms 12/17/2014
Evolva A/S Unloads EV-035 Series To Emergent BioSolutions (EBS) For $70.5 Million Plus 12/17/2014
Emergent BioSolutions (EBS) Expands Biodefense Franchise; Acquires Portfolio Of Broad Spectrum Antibiotics 12/17/2014
Novartis AG (NVS) Takes Stake In Israeli Biopharma BioLine; Makes $10 Million Investment 12/16/2014
Renmatix Acquires Sweden-Based REAC Fuel's Intellectual Property 12/16/2014
Geron Corporation (GERN) Announces Early HSR Clearance For Global Strategic Collaboration With Janssen Biotech Inc. (JNJ) 12/16/2014
PerkinElmer, Inc. (PKI) Completes Acquisition Of Perten Instruments 12/16/2014
Baxter International, Inc. (BAX) To Divest Vero Cell Vaccines Platform To Nanotherapeutics 12/15/2014
Endo International (ENDP) Registration Statement Relating To Pending Auxilium Pharmaceuticals (AUXL) Acquisition Declared Effective By The SEC 12/12/2014
Abbott Laboratories (ABT) Completes Acquisition Of Veropharm 12/12/2014
Sosei Group Corporation Acquires Jitsubo, A Leading Japanese Peptide Technology Company 12/12/2014
Cipla Ltd. Sells Stake In Jiangsu Cdymax Pharma For $18.5 Million 12/12/2014
Danaher (DHR) Completes Acquisition Of Nobel Biocare (NOBN.VX) 12/11/2014
Migranade, Inc. Initiates Negotiations To Acquire The Exclusive World-Wide Rights To Manufacture And Market Itonis, Inc.'s EMESYL Nausea Relief 12/11/2014
Drug Giant Merck & Co. (MRK) Buys Cubist Pharmaceuticals, Inc. (CBST) For $9.5 Billion 12/11/2014
Interim CEO Says Sanofi (SAN.PA) Continuing Diversification, Eyeing Acquisitions 12/10/2014
Valeant (VRX) To Drop Deal-Making To Cut Debt, Boost Stock 12/10/2014
Endo Pharmaceuticals (ENDP) Completes Acquisition Of Rights To Natesto Testosterone Nasal Gel 12/9/2014



//-->